Cambridge Investment Research Advisors
LVGO

Cambridge Investment Research Advisors’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,201
Closed -$2.13M – 2813
2020
Q3 		$2.13M Sell
15,201
-5,913
-28% -$720K 0.01% 772
2020
Q2 		$1.59M Buy
+21,114
New +$1.11M 0.01% 878

Cambridge Investment Research Advisors's LVGO Position: Q4 2020 in Review

Cambridge Investment Research Advisors sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 15,201 shares — an estimated $2.13M sold.

Cambridge Investment Research Advisors first reported a position in LVGO in Q2 2020 and held it in 2 quarters. The position peaked at $2.13M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Cambridge Investment Research Advisors reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 15,201 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $2.13M.
  • Cambridge Investment Research Advisors first reported a position in Livongo Health, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Livongo Health, Inc. Common Stock position peaked at $2.13M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.